Orexigen Therapeutics Reports Corporate and Financial Results for the First Quarter Ended March 31, 2014

[PR Newswire] – SAN DIEGO, May 8, 2014 /PRNewswire/ — Orexigen ® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced corporate and financial results for … more

View todays social media effects on OREX

View the latest stocks trending across Twitter. Click to view dashboard

See who Orexigen is hiring next, click here to view